Skip to main navigation Skip to search Skip to main content

Resmetirom: the first approved therapy for treating metabolic dysfunction associated steatohepatitis

Sheena Bhushan, Aalam Sohal, Mazen Noureddin, Kris V. Kowdley

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Resmetirom: the first approved therapy for treating metabolic dysfunction associated steatohepatitis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science